Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1351 AL 1365

Effects of repetitive transcranial magnetic stimulation on improvement of cognition in elderly patients with cognitive impairment: a systematic review and meta-analysis

Cheng CPW, Wong CSM, Lee KK, Chan APK, Yeung JWF, Chan WC.

Int J Geriatr Psychiatry. 2018 Jan;33(1):e1-e13. doi: 10.1002/gps.4726. Epub 2017 May 11.

Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment

Knezevic D, Mizrahi R.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):123-131. doi: 10.1016/j.pnpbp.2017.05.007. Epub 2017 May 19.

Psychosis and dementia: risk factor, prodrome, or cause?

Fischer CE, Agüera-Ortiz L.

Int Psychogeriatr. 2018 Feb;30(2):209-219. doi: 10.1017/S1041610217000874. Epub 2017 May 31.

Síntomas neuropsiquiátricos como factor de confusión en la detección de la demencia

Córcoles D, Malagón A, Bellsolà M, Gonzalez A, Cortizo R, Leon J, Bulbena A, Pérez V, Martín LM.

Aten Primaria. 2018 May;50(5):267-273. doi: 10.1016/j.aprim.2017.01.015. Epub 2017 Jun 13.

A comparison between the Mini-Mental State Examination and Montreal Cognitive Assessment in assessing cognitive function in patients with diabetes-related dementia

Yamakawa H, Okita M, Fukasawa R, Hatanaka H, Namioka N, Hanyu H.

Psychogeriatrics. 2018 Jan;18(1):72-73. doi: 10.1111/psyg.12277. Epub 2017 Jun 30.

Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms: A Cluster Randomized Controlled Trial

Lichtwarck B, Selbaek G, Kirkevold Ø, Rokstad AMM, Benth JŠ, Lindstrøm JC, Bergh S.

Am J Geriatr Psychiatry. 2018 Jan;26(1):25-38. doi: 10.1016/j.jagp.2017.05.015. Epub 2017 Jun 1.

Prevention of cognitive impairment: scientific guidance and windows of opportunity

Gorelick PB.

J Neurochem. 2018 Mar;144(5):609-616. doi: 10.1111/jnc.14113. Epub 2017 Aug 16.

A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease

Croteau E, Castellano CA, Fortier M, Bocti C, Fulop T, Paquet N, Cunnane SC.

Exp Gerontol. 2018 Jul 1;107:18-26. doi: 10.1016/j.exger.2017.07.004. Epub 2017 Jul 12.

Neuropsychological tools to predict conversion from amnestic mild cognitive impairment to dementia. The TREDEM Registry

Gallucci M, Di Battista ME, Battistella G, Falcone C, Bisiacchi PS, Di Giorgi E.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Jul;25(4):550-560. doi: 10.1080/13825585.2017.1349869. Epub 2017 Jul 18.

Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease

Lai AY, McLaurin J.

J Neurochem. 2018 Mar;144(5):659-668. doi: 10.1111/jnc.14130. Epub 2017 Aug 29.

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone

Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC.

Genet Med. 2018 Jan;20(1):132-141. doi: 10.1038/gim.2017.103. Epub 2017 Jul 20.

Dementia risk and prevention by targeting modifiable vascular risk factors

Tariq S, Barber PA.

J Neurochem. 2018 Mar;144(5):565-581. doi: 10.1111/jnc.14132. Epub 2017 Sep 6.

Adaptation and validation into Portuguese language of the six-item cognitive impairment test (6CIT)

Apóstolo JLA, Paiva DDS, Silva RCGD, Santos EJFD, Schultz TJ.

Aging Ment Health. 2018 Sep;22(9):1184-1189. doi: 10.1080/13607863.2017.1348473. Epub 2017 Jul 25.

Changing clinical phenotypes of HIV-associated neurocognitive disorders

Sacktor N.

J Neurovirol. 2018 Apr;24(2):141-145. doi: 10.1007/s13365-017-0556-6. Epub 2017 Jul 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias